Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Benson

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemRobert O Hughes, John K Walker, Jerry W Cubbage, et al.
Science (New York, N.Y.)|January 16, 2003
RetractionStephen T Davis, Bill G Benson, H Neal Bramson, et al.
Journal of Medicinal Chemistry|March 4, 2010
Design, synthesis, and biological evaluation of 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent, orally active, brain penetrant inhibitor of phosphodiesterase 5 (PDE5)Robert O Hughes, D Joseph Rogier, E Jon Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2011
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinaseShaun R Selness, Terri L Boehm, John K Walker, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2011
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinaseShaun R Selness, Rajesh V Devraj, Balekudru Devadas, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsDafydd R Owen, John K Walker, E Jon Jacobsen, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemRobert O Hughes, John K Walker, Jerry W Cubbage, et al.
Science (New York, N.Y.)|January 16, 2003
RetractionStephen T Davis, Bill G Benson, H Neal Bramson, et al.
Journal of Medicinal Chemistry|March 4, 2010
Design, synthesis, and biological evaluation of 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a potent, orally active, brain penetrant inhibitor of phosphodiesterase 5 (PDE5)Robert O Hughes, D Joseph Rogier, E Jon Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2011
Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinaseShaun R Selness, Terri L Boehm, John K Walker, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2011
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinaseShaun R Selness, Rajesh V Devraj, Balekudru Devadas, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsDafydd R Owen, John K Walker, E Jon Jacobsen, et al.
Pageof 17